-
Hannah
Ben‐bassats,
N.
Goldblum,
S.
Mitrani,
T.
Goldblum,
J.
Yoffey,
M.
Cohen,
Z.
Bentwich,
B.
Ramot,
E.
Klein,
G.
Klein
(1977)
Establishment in continuous culture of a new type of lymphocyte from a “burkitt‐like” malignant lymphoma (line d.g.‐75)
International Journal of Cancer, 19
-
M.
Woisetschlaeger,
C.
Yandava,
L.
Furmanski,
J.
Strominger,
S.
Speck
(1990)
Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes.
Proceedings of the National Academy of Sciences of the United States of America, 87 5
-
C.
Gregory,
M.
Rowe,
A.
Rickinson
(1990)
Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
The Journal of general virology, 71 ( Pt 7)
-
G.
Parker,
R.
Touitou,
M.
Allday
(2000)
Epstein-Barr virus EBNA3C can disrupt multiple cell cycle checkpoints and induce nuclear division divorced from cytokinesis
Oncogene, 19
-
Fiona
Nitsche,
A.
Bell,
A.
Rickinson
(1997)
Epstein-Barr virus leader protein enhances EBNA-2-mediated transactivation of latent membrane protein 1 expression: a role for the W1W2 repeat domain
Journal of Virology, 71
-
S.
Moreno,
P.
Nurse
(1990)
Substrates for p34
cdc2
: In vivo veritas?
Cell, 61
-
M.
Woisetschlaeger,
J.
Strominger,
S.
Speck
(1989)
Mutually exclusive use of viral promoters in Epstein-Barr virus latently infected lymphocytes.
Proceedings of the National Academy of Sciences of the United States of America, 86 17
-
R.
Fåhraeus,
H.
Fu,
I.
Ernberg,
J.
Finke,
M.
Rowe,
G.
Klein,
K.
Falk,
E.
Nilsson,
M.
Yadav,
P.
Busson,
T.
Tursz,
B.
Kallin
(1988)
Expression of Epstein‐Barr virus‐encoded proteins in nasopharyngeal carcinoma
International Journal of Cancer, 42
-
(1989)
Transcription of Epstein-Barr virus in latently infected growth-transformed lymphocytes
-
T.
Henkel,
P.
Ling,
S.
Hayward,
M.
Peterson
(1994)
Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa.
Science, 265 5168
-
B.
Kerr,
A.
Lear,
Martin
Rowe,
D.
Croom-carter,
Lawrence
Young,
S.
Rookes,
P.
Gallimore,
A.
Rickinson
(1992)
Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: cell phenotype dependence of virus promoter usage.
Virology, 187 1
-
A.
Yokoyama,
Michiko
Tanaka,
G.
Matsuda,
Kentaro
Kato,
M.
Kanamori,
H.
Kawasaki,
H.
Hirano,
I.
Kitabayashi,
M.
Ohki,
K.
Hirai,
Y.
Kawaguchi
(2001)
Identification of Major Phosphorylation Sites of Epstein-Barr Virus Nuclear Antigen Leader Protein (EBNA-LP): Ability of EBNA-LP To Induce Latent Membrane Protein 1 Cooperatively with EBNA-2 Is Regulated by Phosphorylation
Journal of Virology, 75
-
N.
Fujitani,
M.
Kanagawa,
T.
Aizawa,
T.
Ohkubo,
S.
Kaya,
M.
Demura,
K.
Kawano,
S.
Nishimura,
K.
Taniguchi,
K.
Nitta
(2003)
Structure determination and conformational change induced by tyrosine phosphorylation of the N-terminal domain of the alpha-chain of pig gastric H+/K+-ATPase.
Biochemical and biophysical research communications, 300 1
-
E.
Nigg
(1995)
Cyclin‐dependent protein kinases: Key regulators of the eukaryotic cell cycle
BioEssays, 17
-
E.
Kieff
(1996)
Epstein-Barr virus and its replication
-
David
Wang,
'.
Liebowitz,
'.
Wang,
C.
Gregory,
A.
Rickinson,
R.
Larson,
T.
Springer,
Elliott
KIEFFl
(1988)
Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity
Journal of Virology, 62
-
N.
Sung,
J.
Wilson,
M.
Davenport,
N.
Sista,
J.
Pagano
(1994)
Reciprocal regulation of the Epstein-Barr virus BamHI-F promoter by EBNA-1 and an E2F transcription factor
Molecular and Cellular Biology, 14
-
Xiao
Tong,
Fred
Wang,
Catherine
Thut,
E.
Kieff
(1995)
The Epstein-Barr virus nuclear protein 2 acidic domain can interact with TFIIB, TAF40, and RPA70 but not with TATA-binding protein
Journal of Virology, 69
-
M.
Sauter,
N.
Mueller‐Lantzsch
(1987)
Characterization of an Epstein-Barr virus nuclear antigen 2 variant (EBNA 2B) by specific sera.
Virus research, 8 2
-
T.
Terasima,
L.
Tolmach
(1963)
Growth and nucleic acid synthesis in synchronously dividing populations of HeLa cells.
Experimental cell research, 30
-
Y.
Ling,
C.
Tornos,
R.
Perez-soler
(1998)
Phosphorylation of Bcl-2 Is a Marker of M Phase Events and Not a Determinant of Apoptosis*
The Journal of Biological Chemistry, 273
-
G.
Laux,
Frank
Dugrillon,
Christine
Eckert,
Brigitte
Adam,
U.
Zimber-Strobl,
G.
Bornkamm
(1994)
Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes
Journal of Virology, 68
-
T.
Lindahl,
A.
Adams,
G.
Bjursell,
G.
Bornkamm,
C.
Kaschka-Dierich,
Ulrich
Jehn
(1976)
Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line.
Journal of molecular biology, 102 3
-
S.
Grossman,
E.
Johannsen,
Xiao
Tong,
Ram
Yalamanchili,
E.
Kieff
(1994)
The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein.
Proceedings of the National Academy of Sciences of the United States of America, 91 16
-
I.
Ruf,
J.
Sample
(1999)
Repression of Epstein-Barr Virus EBNA-1 Gene Transcription by pRb during Restricted Latency
Journal of Virology, 73
-
J.
Shaw,
L.
Levinger,
C.
Carter
(1979)
Nucleosomal structure of Epstein-Barr virus DNA in transformed cell lines
Journal of Virology, 29
-
M.
Davenport,
J.
Pagano
(1999)
Expression of EBNA-1 mRNA Is Regulated by Cell Cycle during Epstein-Barr Virus Type I Latency
Journal of Virology, 73
-
So-Fai
Tsang,
Fred
Wang,
K.
Izumi,
E.
Kieff
(1991)
Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression
Journal of Virology, 65
-
F.
Grässer,
S.
Göttel,
P.
Haiss,
B.
Boldyreff,
O.
Issinger,
N.
Mueller‐Lantzsch
(1992)
Phosphorylation of the Epstein-Barr virus nuclear antigen 2.
Biochemical and biophysical research communications, 186 3
-
A.
Sjöblom,
Annika
Nerstedt,
A.
Jansson,
Lars
Rymo
(1995)
Domains of the Epstein-Barr virus nuclear antigen 2 (EBNA2) involved in the transactivation of the latent membrane protein 1 and the EBNA Cp promoters.
The Journal of general virology, 76 ( Pt 11)
-
L.
Young,
C.
Alfieri,
K.
Hennessy,
H.
Evans,
C.
O'Hara,
K.
Anderson,
J.
Ritz,
R.
Shapiro,
A.
Rickinson,
E.
Kieff,
J.
Cohen
(1989)
Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease.
The New England journal of medicine, 321 16
-
A.
Sjöblom,
A.
Jansson,
Weiwen
Yang,
Sonia
Lain,
Tina
Nilsson,
L.
Rymo
(1995)
PU box-binding transcription factors and a POU domain protein cooperate in the Epstein-Barr virus (EBV) nuclear antigen 2-induced transactivation of the EBV latent membrane protein 1 promoter.
The Journal of general virology, 76 ( Pt 11)
-
P.
Ling,
J.
Hsieh,
I.
Ruf,
D.
Rawlins,
S.
Hayward
(1994)
EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1
Journal of Virology, 68
-
B.
Contreras-Brodin,
M.
Anvret,
S.
Imreh,
E.
Altiok,
G.
Klein,
M.
Masucci
(1991)
B cell phenotype-dependent expression of the Epstein-Barr virus nuclear antigens EBNA-2 to EBNA-6: studies with somatic cell hybrids.
The Journal of general virology, 72 ( Pt 12)
-
A.
Morla,
G.
Draetta,
D.
Beach,
Jean
Wang
(1989)
Reversible tyrosine phosphorylation of cdc2: Dephosphorylation accompanies activation during entry into mitosis
Cell, 58
-
Y.
Furukawa,
S.
Iwase,
Y.
Terui,
J.
Kikuchi,
T.
Sakai,
Mitsuru
Nakamura,
S.
Kitagawa,
M.
Kitagawa
(1996)
Transcriptional Activation of the cdc2 Gene Is Associated with Fas-induced Apoptosis of Human Hematopoietic Cells*
The Journal of Biological Chemistry, 271
-
C.
Yandava,
S.
Speck
(1992)
Characterization of the deletion and rearrangement in the BamHI C region of the X50-7 Epstein-Barr virus genome, a mutant viral strain which exhibits constitutive BamHI W promoter activity
Journal of Virology, 66
-
Xiao
Tong,
Ronny
Drapkin,
Danny
Reinberg,
Elliott
Kieff
(1995)
The 62- and 80-kDa subunits of transcription factor IIH mediate the interaction with Epstein-Barr virus nuclear protein 2.
Proceedings of the National Academy of Sciences of the United States of America, 92
-
D.
Dumont,
P.
Branton
(1992)
Phosphorylation of adenovirus E1A proteins by the p34cdc2 protein kinase.
Virology, 189 1
-
L.
Young,
E.
Deacon,
M.
Rowe,
J.
Crocker,
H.
Herbst,
G.
Niedobitek,
S.
Hamilton-Dutoit,
G.
Pallesen
(1991)
Epstein-Barr virus latent genes in tumour cells of Hodgkin's disease
The Lancet, 337
-
L.
Decker,
L.
Klaman,
D.
Thorley-Lawson
(1996)
Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals
Journal of Virology, 70
-
Bernhard
Lüscher,
R.
Eisenman
(1992)
Mitosis-specific phosphorylation of the nuclear oncoproteins Myc and Myb
The Journal of Cell Biology, 118
-
Fred.,
Wang,
C.
Gregory,
C.
Sample,
M.
Rowe,
David,
Liebowitz,
Ruth
Murray,
A.
Rickinson,
E.
Kieff
(1990)
Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23
Journal of Virology, 64
-
(1998)
Phosphorylation of Bcl-2 is VOL
-
L.
Gurley,
Joseph
Valdez,
J.
Buchanan
(1995)
Characterization of the Mitotic Specific Phosphorylation Site of Histone H1
The Journal of Biological Chemistry, 270
-
J.
Gottesfeld,
D.
Forbes
(1997)
Mitotic repression of the transcriptional machinery.
Trends in biochemical sciences, 22 6
-
Sibylle
Mittnacht
(1998)
Control of pRB phosphorylation.
Current opinion in genetics & development, 8 1
-
Lisa
Petti,
C.
Sample,
E.
Kieff
(1990)
Subnuclear localization and phosphorylation of Epstein-Barr virus latent infection nuclear proteins.
Virology, 176 2
-
M.
Voss,
A.
Hille,
S.
Barth,
Andreas
Spurk,
F.
Hennrich,
D.
Holzer,
N.
Mueller‐Lantzsch,
E.
Kremmer,
F.
Grässer
(2001)
Functional Cooperation of Epstein-Barr Virus Nuclear Antigen 2 and the Survival Motor Neuron Protein in Transactivation of the Viral LMP1 Promoter
Journal of Virology, 75
-
N.
Sung,
S.
Kenney,
D.
Gutsch,
Joseph
Pagano
(1991)
EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus
Journal of Virology, 65
-
L.
Spender,
G.
Cornish,
Benjamin
Rowland,
B.
Kempkes,
P.
Farrell
(2001)
Direct and Indirect Regulation of Cytokine and Cell Cycle Proteins by EBNA-2 during Epstein-Barr Virus Infection
Journal of Virology, 75
-
J.
Usukura,
Y.
Nishizawa,
Atsushi
Shimomura,
Kazuto
Kobayashi,
T.
Nagatsu,
M.
Hagiwara
(2000)
Direct imaging of phosphorylation‐dependent conformational change and DNA binding of CREB by electron microscopy
Genes to Cells, 5
-
K.
Haller,
Yalin
Wu,
E.
Derow,
Iris
Schmitt,
K.
Jeang,
R.
Grassmann
(2002)
Physical Interaction of Human T-Cell Leukemia Virus Type 1 Tax with Cyclin-Dependent Kinase 4 Stimulates the Phosphorylation of Retinoblastoma Protein
Molecular and Cellular Biology, 22
-
A.
Whitmarsh,
R.
Davis
(2000)
Regulation of transcription factor function by phosphorylation
Cellular and Molecular Life Sciences CMLS, 57
-
J.
Dillner,
B.
Kallin,
G.
Klein,
H.
Jörnvall,
H.
Alexander,
R.
Lerner
(1985)
Antibodies against synthetic peptides react with the second Epstein‐Barr virus‐associated nuclear antigen.
The EMBO Journal, 4
-
J.
Gage,
C.
Meyers,
F.
Wettstein
(1990)
The E7 proteins of the nononcogenic human papillomavirus type 6b (HPV-6b) and of the oncogenic HPV-16 differ in retinoblastoma protein binding and other properties
Journal of Virology, 64
-
H.
Nakajima,
Fumiko
Toyoshima-Morimoto,
Eri
Taniguchi,
E.
Nishida
(2003)
Identification of a Consensus Motif for Plk (Polo-like Kinase) Phosphorylation Reveals Myt1 as a Plk1 Substrate*
Journal of Biological Chemistry, 278
-
A.
Leresche,
V.
Wolf,
J.
Gottesfeld
(1996)
Repression of RNA polymerase II and III transcription during M phase of the cell cycle.
Experimental cell research, 229 2
-
S.
Advani,
R.
Weichselbaum,
B.
Roizman
(2001)
cdc2 Cyclin-Dependent Kinase Binds and Phosphorylates Herpes Simplex Virus 1 UL42 DNA Synthesis Processivity Factor
Journal of Virology, 75
-
Neil
Segil,
M.
Guermah,
A.
Hoffmann,
R.
Roeder,
Nathaniel
Heintz
(1996)
Mitotic regulation of TFIID: inhibition of activator-dependent transcription and changes in subcellular localization.
Genes & development, 10 19
-
J.
Pines,
T.
Hunter
(1989)
Isolation of a human cyclin cDNA: Evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2
Cell, 58
-
P.
Hartl,
J.
Gottesfeld,
D.
Forbes
(1993)
Mitotic repression of transcription in vitro
The Journal of Cell Biology, 120
-
(1993)
Characterization of cis-acting elements of the BamHI-F promoter of EBV, p. 239–242
-
J.
Sample,
E.
Henson,
C.
Sample
(1992)
The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated
Journal of Virology, 66
-
J.
Dillner,
V.
Wendel-Hansen,
Gunilla
Kjellström,
B.
Kallin,
A.
Rosén
(1988)
Purification and characterization of the epstein‐barr virus nuclear antigen 2 using monoclonal antipeptide antibodies
International Journal of Cancer, 42
-
E.
Miyashita,
Bin
Yang,
G.
Babcock,
D.
Thorley-Lawson
(1998)
Identification of the Site of Epstein-Barr Virus Persistence In Vivo as a Resting B Cell
Journal of Virology, 72
-
M.
Kitay,
D.
Rowe
(1996)
Cell cycle stage-specific phosphorylation of the Epstein-Barr virus immortalization protein EBNA-LP
Journal of Virology, 70
-
M.
Lowe,
C.
Rabouille,
N.
Nakamura,
R.
Watson,
M.
Jackman,
E.
Jämsä,
D.
Rahman,
D.
Pappin,
G.
Warren
(1998)
Cdc2 Kinase Directly Phosphorylates the cis-Golgi Matrix Protein GM130 and Is Required for Golgi Fragmentation in Mitosis
Cell, 94
-
David
Wang,
D.
Liebowitz,
E.
Kieff
(1985)
An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells
Cell, 43
-
Lian
Wang,
Steven
Grossman,
E.
Kieff
(2000)
Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter.
Proceedings of the National Academy of Sciences of the United States of America, 97 1
-
E.
Johannsen,
Eugene
Koh,
G.
Mosialos,
Xiao
Tong,
E.
Kieff,
Steven
Grossman
(1995)
Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1
Journal of Virology, 69
-
M.
Fulco,
A.
Costanzo,
P.
Merlo,
Rosamaria
Mangiacasale,
S.
Strano,
G.
Blandino,
C.
Balsano,
P.
Lavia,
M.
Levrero
(2003)
p73 Is Regulated by Phosphorylation at the G2/M Transition*
Journal of Biological Chemistry, 278
-
Xiao
Tong,
R.
Drapkin,
Ram
Yalamanchili,
G.
Mosialos,
E.
Kieff
(1995)
The Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIE
Molecular and Cellular Biology, 15
-
S.
Harada,
E.
Kieff
(1997)
Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation
Journal of Virology, 71
-
C.
Meitinger,
L.
Strobl,
G.
Marschall,
G.
Bornkamm,
U.
Zimber-Strobl
(1994)
Crucial sequences within the Epstein-Barr virus TP1 promoter for EBNA2-mediated transactivation and interaction of EBNA2 with its responsive element
Journal of Virology, 68
-
T.
Hunter,
M.
Karin
(1992)
The regulation of transcription by phosphorylation
Cell, 70
-
G.
Wilson,
G.
Miller
(1979)
Recovery of Epstein-Barr virus from nonproducer neonatal human lymphoid cell transformants.
Virology, 95 2
-
Friedrich
Grasser,
P.
Haiss,
Susanne
Gottel,
Nikolaus
Mueller-Lantzsch
(1991)
Biochemical characterization of Epstein-Barr virus nuclear antigen 2A
Journal of Virology, 65
-
S.
Herwig,
M.
Strauss
(1997)
The retinoblastoma protein: a master regulator of cell cycle, differentiation and apoptosis.
European journal of biochemistry, 246 3
-
C.
Gorman,
L.
Moffat,
B.
Howard
(1982)
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells
Molecular and Cellular Biology, 2
-
P.
Levine,
D.
Ablashi,
G.
Pearson,
S.
Kottaridis
(2011)
Epstein-Barr Virus and Associated Diseases
-
Jeffrey
Lin,
E.
Johannsen,
E.
Robertson,
E.
Kieff
(2002)
Epstein-Barr Virus Nuclear Antigen 3C Putative Repression Domain Mediates Coactivation of the LMP1 Promoter with EBNA-2
Journal of Virology, 76
-
G.
Miller,
J.
Robinson,
L.
Heston,
M.
Lipman
(1974)
Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference.
Proceedings of the National Academy of Sciences of the United States of America, 71 10
-
Kentaro
Kato,
A.
Yokoyama,
Y.
Tohya,
H.
Akashi,
Y.
Nishiyama,
Y.
Kawaguchi
(2003)
Identification of protein kinases responsible for phosphorylation of Epstein-Barr virus nuclear antigen leader protein at serine-35, which regulates its coactivator function.
The Journal of general virology, 84 Pt 12
-
C.
Sexton,
J.
Pagano
(1989)
Analysis of the Epstein-Barr virus origin of plasmid replication (oriP) reveals an area of nucleosome sparing that spans the 3' dyad
Journal of Virology, 63
-
M.
Gulley,
M.
Raphael,
C.
Lutz,
D.
Ross,
N.
Raab-Traub
(1992)
Epstein‐barr virus integration in human lymphomas and lymphoid cell lines
Cancer, 70
-
Fred
Wang,
S.
Tsang,
M.
Kurilla,
J.
Cohen,
E.
Kieff
(1990)
Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1
Journal of Virology, 64
-
G.
Miller,
L.
Heston,
G.
Hoffman
(1982)
Neutralization of lymphocyte immortalization by different strains of Epstein-Barr virus with a murine monoclonal antibody
Infection and Immunity, 37
-
M.
Pagano,
R.
Pepperkok,
F.
Verde,
W.
Ansorge,
G.
Draetta
(1992)
Cyclin A is required at two points in the human cell cycle.
The EMBO Journal, 11